NEW YORK, Dec. 18, 2015 /PRNewswire/ -- Kalorama Information notes an interesting trend: that as healthcare approaches a revolution in terms of the resolution of disease (and its personalization), related basic research appears to be undergoing its own transformation. In a recent blog post, the healthcare market researcher said that segments of the private sector have shown greater appetite for novel modes of thought and new avenues for product development.
Among the new benefactors of U.S. basic research has been the tech industry.
In the past year, the tech giants of Google, Apple and Microsoft have proceeded to deepen their involvement in healthcare. These companies still embrace the business opportunities available at the terminal of product pipelines, but now seek to facilitate fundamental medical research capable of attracting even more diverse collaborators and opening broader market horizons.
"While tech companies have been characterized by the luster of 'disruption', the role of information technology (IT) in healthcare has been that of a patch, at best seamlessly integrated with and potentiating various devices and medical procedures," said Emil Salazar, Kalorama analyst and author of the blog post.
Kalorama said that basic research is fundamental to the introduction of medicine, medical technologies and other marketable healthcare products. Its bewildering scope or the experimental freedom necessary for market-significant discoveries requires tremendous resources with relative inattention to profitability or return. If pharmaceuticals, medical devices and diagnostics are what emerge from the spigot of translational research workflows, basic research is the well – continually being dug deeper to access wider tables of knowledge. The profundity of basic research has typically been met by only the largest players; government and organizations in the public sphere traditionally sponsor basic research due to their unique ability to marshal broad resources whether human or fiscal.
Most recently, Alphabet (holding company created in 2015 by Google) introduced its medical research company Verily, formerly Google Life Sciences. The announcement came as Verily graduated to an independent subsidiary under Alphabet. As one of the Google 'moon shot' initiatives, Verily is focused on actualizing the transition of healthcare from episodic and reactive to proactive and preventative. Central to the paradigm shift envisioned by Verily is its "baseline" study and the investigation of "healthiness" along biological, genetic, behavioral and environmental factors manageable and analyzable by Alphabet as data.
Kalorama Information provides extensive research into how technology is forming healthcare with titles including The Market for Wearable Devices, Big Data and Healthcare, and EMR 2015: The Market for Electronic Medical Records.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.
We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.
Contact:
Bruce Carlson
(212) 807-2622
[email protected]
www.KaloramaInformation.com
Logo - http://photos.prnewswire.com/prnh/20150831/262422LOGO
SOURCE Kalorama Information
Share this article